These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28396625)

  • 1. CD133-Positive Membrane Particles in Cerebrospinal Fluid of Patients with Inflammatory and Degenerative Neurological Diseases.
    Bobinger T; May L; Lücking H; Kloska SP; Burkardt P; Spitzer P; Maler JM; Corbeil D; Huttner HB
    Front Cell Neurosci; 2017; 11():77. PubMed ID: 28396625
    [No Abstract]   [Full Text] [Related]  

  • 2. Variation of membrane particle-bound CD133 in cerebrospinal fluid of patients with subarachnoid and intracerebral hemorrhage.
    Bobinger T; Roeder SS; Spruegel MI; Froehlich K; Beuscher VD; Hoelter P; Lücking H; Corbeil D; Huttner HB
    J Neurosurg; 2021 Feb; 134(2):600-607. PubMed ID: 31978876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased membrane shedding--indicated by an elevation of CD133-enriched membrane particles--into the CSF in partial epilepsy.
    Huttner HB; Corbeil D; Thirmeyer C; Coras R; Köhrmann M; Mauer C; Kuramatsu JB; Kloska SP; Doerfler A; Weigel D; Klucken J; Winkler J; Pauli E; Schwab S; Hamer HM; Kasper BS
    Epilepsy Res; 2012 Mar; 99(1-2):101-6. PubMed ID: 22130040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease.
    Huttner HB; Janich P; Köhrmann M; Jászai J; Siebzehnrubl F; Blümcke I; Suttorp M; Gahr M; Kuhnt D; Nimsky C; Krex D; Schackert G; Löwenbrück K; Reichmann H; Jüttler E; Hacke W; Schellinger PD; Schwab S; Wilsch-Bräuninger M; Marzesco AM; Corbeil D
    Stem Cells; 2008 Mar; 26(3):698-705. PubMed ID: 18096722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.
    Contini C; Cultrera R; Seraceni S; Castellazzi M; Granieri E; Fainardi E
    Mult Scler; 2004 Aug; 10(4):360-9. PubMed ID: 15327030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis.
    Annunziata P; Pluchino S; Martino T; Guazzi G
    J Neuroimmunol; 1997 Jul; 77(1):128-33. PubMed ID: 9209277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
    Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
    Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis.
    Satoh J; Yukitake M; Kurohara K; Takashima H; Kuroda Y
    J Neurol Sci; 2003 Aug; 212(1-2):11-20. PubMed ID: 12809994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Levels of Kynurenic Acid in the Cerebrospinal Fluid in Patients with Hydrocephalus.
    Kepplinger B; Baran H; Kronsteiner C; Reuss J
    Neurosignals; 2019; 27(1):1-11. PubMed ID: 31059212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.
    Silber E; Semra YK; Gregson NA; Sharief MK
    Neurology; 2002 May; 58(9):1372-81. PubMed ID: 12011283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis.
    Stampanoni Bassi M; Iezzi E; Drulovic J; Pekmezovic T; Gilio L; Furlan R; Finardi A; Marfia GA; Sica F; Centonze D; Buttari F
    Front Cell Neurosci; 2020; 14():120. PubMed ID: 32655367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
    Simone IL; Federico F; Trojano M; Tortorella C; Liguori M; Giannini P; Picciola E; Natile G; Livrea P
    J Neurol Sci; 1996 Dec; 144(1-2):182-90. PubMed ID: 8994122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
    Jongen PJ; Lamers KJ; Doesburg WH; Lemmens WA; Hommes OR
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):446-51. PubMed ID: 9343121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.